Vera Therapeutics, Inc. (VERA)

Vera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	45.68	43.46	79.67	53.7	3.2
Short-Term Investments	115.04	71.19	0	0	0
Cash & Cash Equivalents	160.72	114.65	79.67	53.7	3.2
Cash Growth	40.18%	43.90%	48.36%	1580.88%	-
Other Current Assets	11.31	11.05	2.86	0.56	0.37
Total Current Assets	172.02	125.7	82.54	54.26	3.57
Property, Plant & Equipment	3.04	5.22	0	0	1.39
Long-Term Investments	0.01	0.06	0.87	0	0
Other Long-Term Assets	0.47	0.46	0.34	0.29	0.42
Total Long-Term Assets	3.52	5.74	1.21	0.29	1.82
Total Assets	175.55	131.44	83.75	54.55	5.38
Accounts Payable	11.12	11.99	1.39	0.91	0.34
Current Debt	2.44	2.65	0	0	0.12
Other Current Liabilities	8.75	10.96	6.31	1.5	0.6
Total Current Liabilities	22.3	25.6	7.69	2.41	1.06
Long-Term Debt	51.27	28.64	4.92	0	0.01
Other Long-Term Liabilities	0.29	0.29	1.54	1.92	0.76
Total Long-Term Liabilities	51.56	28.93	6.47	1.92	0.77
Total Liabilities	73.86	54.53	14.16	4.33	1.83
Total Debt	53.71	31.29	4.92	0	0.13
Debt Growth	71.67%	535.51%	-	-	-
Retained Earnings	-309.1	-213.11	-124.06	-91.45	-38.03
Comprehensive Income	0.25	-0.22	0	0	0
Shareholders' Equity	101.69	76.91	69.59	-89.35	-36.55
Net Cash / Debt	107.01	83.37	74.75	53.7	3.06
Net Cash / Debt Growth	28.36%	11.53%	39.19%	1653.31%	-
Net Cash Per Share	2.51	3.14	5.56	167.84	10.37
Working Capital	149.72	100.1	74.85	51.86	2.51
Book Value Per Share	2.38	2.89	5.18	-279.25	-123.75

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).